226 related articles for article (PubMed ID: 37488783)
1. Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States.
Ferrante ND; Kallan MJ; Sukkestad S; Kodani M; Kitahata MM; Cachay ER; Bhattacharya D; Heath S; Napravnik S; Moore RD; Yendewa G; Mayer KH; Reddy KR; Hayden T; Kamili S; Martin JN; Kim HN; Lo Re V
J Viral Hepat; 2023 Nov; 30(11):879-888. PubMed ID: 37488783
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana.
Baruti K; Phinius BB; Phakedi B; Mpebe G; Choga W; Bhebhe L; Mulenga G; Moraka NO; Ratsoma T; Pretorius-Holme M; Makhema J; Shapiro R; Lockman S; Moyo S; Jongman M; Anderson M; Gaseitsiwe S
J Infect Public Health; 2023 Nov; 16(11):1736-1741. PubMed ID: 37734129
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hepatitis B and delta coinfection in Israel.
Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
[TBL] [Abstract][Full Text] [Related]
8. Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.
Lee CY; Tsai HC; Lee SS; Wu KS; Sy CL; Chen JK; Chen YS
J Microbiol Immunol Infect; 2015 Feb; 48(1):20-7. PubMed ID: 24064291
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis D diagnostics:Utilization and testing in the United States.
Safaie P; Razeghi S; Rouster SD; Privitera I; Sherman KE
Virus Res; 2018 May; 250():114-117. PubMed ID: 29596839
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.
Opaleye OO; Akanbi OA; Osundare FA; Wang B; Adesina O; Oluremi AS; Sunday ST; Akindele AA; Klink P; Bock CT
Virol J; 2021 Jan; 18(1):20. PubMed ID: 33446224
[TBL] [Abstract][Full Text] [Related]
11. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
[TBL] [Abstract][Full Text] [Related]
13. Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania.
Winter A; Letang E; Vedastus Kalinjuma A; Kimera N; Ntamatungiro A; Glass T; Moradpour D; Sahli R; Le Gal F; Furrer H; Wandeler G;
Int J Infect Dis; 2016 May; 46():8-10. PubMed ID: 26996457
[TBL] [Abstract][Full Text] [Related]
14. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
[TBL] [Abstract][Full Text] [Related]
15. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Polaris Observatory Collaborators
J Hepatol; 2024 Feb; 80(2):232-242. PubMed ID: 38030035
[TBL] [Abstract][Full Text] [Related]
16. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.
Katwesigye E; Seremba E; Semitala F; Ocama P
Afr Health Sci; 2017 Dec; 17(4):974-978. PubMed ID: 29937867
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
[TBL] [Abstract][Full Text] [Related]
18. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims Database.
Gish RG; Jacobson IM; Lim JK; Waters-Banker C; Kaushik A; Kim C; Cyhaniuk A; Wong RJ
Hepatology; 2024 May; 79(5):1117-1128. PubMed ID: 37976395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
